Stockholders’ Equity (Details Narrative)															1 Months Ended		12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares shares	Aug. 11, 2021 $ / shares shares	Jul. 29, 2021 shares	Jul. 15, 2021 shares	May 26, 2021	Mar. 31, 2021 USD ($) $ / shares shares	Mar. 26, 2021 $ / shares shares	Feb. 28, 2021 shares	Jan. 31, 2021 USD ($) $ / shares shares	Dec. 04, 2020 shares	Nov. 19, 2020 shares	Jun. 23, 2020 $ / shares shares	Apr. 06, 2020 USD ($) $ / shares shares	Feb. 27, 2020	Sep. 30, 2021 shares	Jan. 31, 2020 $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Jun. 30, 2021 shares	May 24, 2021 $ / shares shares	Jun. 15, 2020 shares	Mar. 27, 2020 shares	Dec. 31, 2019 shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Reverse Stock Split														1-for-10 basis
Common stock, shares authorized	24,000,000																24,000,000	24,000,000	24,000,000	12,000,000
Stock issued during period, shares							2,190,000		1,711,783				493,027
Share price per share | $ / shares							$ 4.32		$ 3.00
Proceeds from public offering | $									$ 4,532,445
Term of warrants							2 years		5 years
Warrants exercise price | $ / shares									$ 3.75
Number of shares, warrants exercised																	495,641	22,438
Warrants to purchase shares of common stock							2,190,000
Warrants exercisable date					May 24, 2021		May 24, 2021
Unrecognized share based compensation cost | $	$ 19,255																$ 19,255	$ 77,187
Preferred stock, shares authorized	10,000,000																10,000,000	10,000,000
Preferred stock, par value | $ / shares	$ 0.001																$ 0.001	$ 0.001
Preferred stock, shares issued	465																465	715
Preferred stock, shares outstanding	465																465	715
Number of shares granted, description																	the Company granted a total of 698,831 options to 35 employees, 4 directors, and 4 consultants with vesting periods ranging from immediately upon issue to three years beginning January 4, 2021	the Company granted a total of 579,998 options to 19 employees, 4 directors, and 5 consultants with vesting periods ranging from immediately upon issue to three years beginning May 1, 2020
Number of shares granted																	698,831	579,998
Vesting period																	3 years	3 years
Share based compensation arrangement by award options vested																	598,789	294,373
Allocation share based compensation expense | $																	$ 1,741,366	$ 854,217
Share based compensation arrangement by award options vested outstanding	1,395,882																1,395,882	713,010					180,912
Stock issued during Stock options exercised	941,934																941,934	349,642
Share based compensation arrangement by award options grants																	5,204
Allocation share based compensation expense | $																	$ 1,066,455	$ 596,842
Options exercise price | $ / shares																	$ 1.84
Stock options compensation cost | $	$ 1,164,723																$ 1,164,723
Weighted average remaining recognition period																	2 years 1 month 6 days
Pre-funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares										22,438
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation arrangement by award options vested outstanding	1,395,882																1,395,882	713,010
Allocation share based compensation expense | $																	$ 1,047,200
2013 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares				1,765,000
Common shares granted for the period															5,204
Common stock capital shares rserved for future isuance				875,000
2013 Stock Option Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock capital shares rserved for future isuance	339,677																339,677
Two Thousand Thirteen Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation arrangement by award options vested outstanding	1,345,882																1,345,882	663,010
2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options exercise price | $ / shares		$ 3.42										$ 2.63
Two Thousand Twenty Twenty Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrecognized share based compensation cost | $	$ 685,503																$ 685,503
Options exercise price | $ / shares																	$ 1.84
Weighted average remaining recognition period																	2 years 4 months 13 days
CorProminence [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares						1,500
Share price per share | $ / shares						$ 4.99
April 2020 Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares						21,591
Number of shares, warrants exercised						191,204
Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price | $ / shares						$ 5.55625
Warrants to purchase shares of common stock						175,200
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrant exercise price						1.25
Series D Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares	87,267																	3,272,048
Conversion of stock, shares converted																		7,404
Preferred stock dividend, shares																		774,940
Preferred stock, shares outstanding	132																132
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share issued and sold during period, shares																1,640
Preferred stock, par value | $ / shares																$ 1,000
Dividends percentage																9.00%
Conversion price per share | $ / shares																$ 2.50
Conversion description																In addition, a holder may at any time, alternatively, convert all, or any part, of its Series D Preferred Shares at an alternative conversion price, which equals the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five (5) trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Shares being redeemed.
Series E Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares	61,651
Series E Convertible Preferred Stock [Member] | Other Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock, shares converted	48,544
Share issued and sold during period, shares	333
Dividends percentage	9.00%
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares						119,000		263,200
Private Placement [Member] | Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Term of warrants						2 years
Warrants exercise price | $ / shares						$ 4.32
Warrants to purchase shares of common stock						2,190,000
Public Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares						2,190,000
Share price per share | $ / shares						$ 4.445
Proceeds from public offering | $						$ 8,736,488							$ 1,230,000
Share issued and sold during period, shares													493,027
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares									136,943
Warrants exercise price | $ / shares							$ 2.61													$ 2.11
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right	3,987,931																3,987,931
Description For Warrant Expiration	expire between February 22, 2022 and January 6, 2026
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares																	3,901,783	493,027
Shares issued for services																		25,851
Common Stock [Member] | Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrant exercise price						0.08
Common Stock [Member] | Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrant exercise price						0.080
Common Stock [Member] | Series D Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock, shares converted						250
Number of shares as in-kind payment, shares						19,000
Pre-funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price | $ / shares													$ 3.64
Warrants to purchase shares of common stock													22,438
Pre-funded Warrants [Member] | Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase shares of common stock													515,465
Stock Options [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Allocation share based compensation expense | $																	$ 596,842	$ 573,232
Placement Agent [Member] | Dawson James Securities, Inc [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase shares of common stock													41,237
President And Chief Executive Officer [Member] | 2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		77,748										60,094
Vice President [Member] | 2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		30,313										12,019
Chief Technology Officer [Member] | 2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		76,304										24,038
Chief Financial Officer [Member] | 2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		48,580										18,028
Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period			10,000								13,500
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized																					8,000,000
Minimum [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price | $ / shares	$ 0.10																$ 0.10
Minimum [Member] | Special Shareholders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized																						2,250,000
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized																		12,000,000
Maximum [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price | $ / shares	$ 40.00																$ 40.00
Maximum [Member] | Special Shareholders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized																						8,000,000